Literature DB >> 7742159

Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan.

K Persson1, S Sjöström, I Sigurdardottir, V Molnár, M Hammarlund-Udenaes, A Rane.   

Abstract

Postoperative pain relief with codeine was evaluated in 11 women undergoing hysterectomy. Patient-controlled analgesia (PCA) was used to administer codeine. After the study the patients were phenotyped with respect to the O-demethylation of dextromethorphan (cytochrome P4502D6 polymorphism). Ten were extensive metabolisers and one a poor metaboliser. There was a nine-fold variation in the minimum plasma concentration of codeine consistent with pain relief (40-350 ng ml-1). Two patients did not experience any effect of codeine, one of whom was a poor metaboliser of dextromethorphan, confirmed by genotyping. In the other nine patients the effective dose of codeine varied from 4.8-25.3 mg h-1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742159      PMCID: PMC1364958          DOI: 10.1111/j.1365-2125.1995.tb04428.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.

Authors:  C A Smith; A C Gough; P N Leigh; B A Summers; A E Harding; D M Maraganore; S G Sturman; A H Schapira; A C Williams; D M Maranganore
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

2.  The effect of N-demethylation on certain pharmacologic actions of morphine, codeine, and meperidine in the mouse.

Authors:  J W MILLER; H H ANDERSON
Journal:  J Pharmacol Exp Ther       Date:  1954-10       Impact factor: 4.030

3.  Mu receptor binding of some commonly used opioids and their metabolites.

Authors:  Z R Chen; R J Irvine; A A Somogyi; F Bochner
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

4.  Dextromethorphan: polymorphic serum pattern of the O-demethylated and didemethylated metabolites in man.

Authors:  O Mortimer; B Lindström; H Laurell; U Bergman; A Rane
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  Polymorphic O-demethylation of codeine.

Authors:  Z R Chen; A A Somogyi; F Bochner
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

6.  Adverse reactions to intravenous codeine phosphate in children. A report of three cases.

Authors:  E C Shanahan; A G Marshall; C P Garrett
Journal:  Anaesthesia       Date:  1983-01       Impact factor: 6.955

7.  Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharm Sci       Date:  1982-12       Impact factor: 3.534

8.  Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.

Authors:  S H Sindrup; K Brøsen; P Bjerring; L Arendt-Nielsen; U Larsen; H R Angelo; L F Gram
Journal:  Clin Pharmacol Ther       Date:  1990-12       Impact factor: 6.875

9.  Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI).

Authors:  P Dayer; J Desmeules; T Leemann; R Striberni
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

10.  Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.

Authors:  Q Y Yue; J O Svensson; C Alm; F Sjöqvist; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

View more
  10 in total

Review 1.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 2.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

Review 3.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Human pharmacogenomic variations and their implications for antifungal efficacy.

Authors:  Joseph Meletiadis; Stephen Chanock; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects.

Authors:  Xiujun Wu; Li Yuan; Jinliang Zuo; Jing Lv; Tao Guo
Journal:  Eur J Clin Pharmacol       Date:  2014-01       Impact factor: 2.953

Review 6.  Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.

Authors:  Jörn Lötsch; Carsten Skarke; Jürgen Liefhold; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

Authors:  V Ozdemir; J Fourie; U Busto; C A Naranjo
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

8.  Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition.

Authors:  Thomas Eissing; Jörg Lippert; Stefan Willmann
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

9.  Pharmacogenetics of analgesic drugs.

Authors:  Roman Cregg; Giovanna Russo; Anthony Gubbay; Ruth Branford; Hiroe Sato
Journal:  Br J Pain       Date:  2013-11

Review 10.  Pharmacogenomics and Opioid Analgesics: Clinical Implications.

Authors:  Eugenia Yiannakopoulou
Journal:  Int J Genomics       Date:  2015-05-14       Impact factor: 2.326

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.